Dr Catherine Kielar

Director

Catherine has over 15 years’ consultancy and research experience and has been involved in a range of projects covering the entire lifecycle of a product, including the development of TPPs, portfolio prioritization, clinical endpoint analysis, the development of value propositions and GVDs, HTA submissions, service optimization and redesign, primary research with clinical experts and payers, advisory boards, focused and systematic reviews, and health economic models.

She has managed projects in a wide range of disease areas (orphan and non-orphan), including oncology, neurodegenerative disorders, hematology, immunological diseases, infectious diseases, metabolic diseases, and mental health.

Catherine holds a PhD in Neuroscience from King’s College London and an MSc in Health Economics and Decision Modelling from the University of Sheffield.